P4HB and Miyoshi myopathy: Interestingly, bortezomib-resistant cell lines were noted to be more sensitive to the inhibition with CCF642-34 compared to bortezomib-naïve cells, which further supported the hypothesis of increased dependence of bortezomib-resistant MM cells on PDIA1.